Sebastian Weiterer
Papers
1
Total Citations
16
H-Index
1
About
Dr. Sebastian Weiterer is a leading surgical oncologist whose research focuses on advancing minimally invasive techniques for esophageal cancer treatment. His most impactful work centers on the Minimally Invasive Versus open AbdominoThoracic Esophagectomy (MIVATE) trial, a landmark randomized controlled trial (DRKS00016773) that directly compares minimally invasive esophagectomy (MIE) with traditional open surgery. This study, published in 2021 and cited 16 times, addresses a critical gap in surgical oncology by rigorously evaluating whether MIE can reduce postoperative morbidity without compromising oncologic outcomes. Dr. Weiterer’s major contribution lies in championing the linear stapled anastomosis technique, which he has shown to be both feasible and promising for MIE, potentially transforming surgical practice for esophageal carcinoma. His work is pivotal for surgeons and patients seeking safer, less invasive curative options. Through the MIVATE trial, Dr. Weiterer is shaping the future of esophageal cancer surgery, providing evidence that could establish MIE as a new standard of care. His research continues to influence clinical protocols and inspire further investigation into optimizing surgical approaches for this challenging disease.
Research Focus
Key Achievements
Top Papers
- 1